Biotechnology from bench to business

• Follow GEN on:
• Login | Register | Subscribe

• ADME/Tox
• Automation
• Bioprocess Scale-Up
• Bioreactors
• Biosimilars
• Cell Culture
• Cell-Based Assays
• Contract Manufacturing
• Gene Therapy
• High-Throughput Screening
• Immunoassay
• Induced Pluripotent Stem Cells
• Informatics
• Liquid Handling
• Pharmacokinetics
• Protein Characterization
• Protein Detection
• Regenerative Medicine
• RNAi/siRNA
• Stem Cells
• Western Blot

• GEN Articles

• More »

• Corporate Profiles: Capturing CTCs for Molecular Analysis
  Cynvenio Biosystems Seeks to Differentiate Itself with Automated LiquidBiopsy Platform
• Insight & Intelligence™: Acquired Drug Resistance in Cancer
  New Methods Allow Non-invasive Analysis in Blood Plasma
• BioPerspectives: Avoiding “Incidental” Damages
  Presidential panel, ACMG, and experts struggle with what patients should learn, and how.
• Feature Articles: Cancer Diagnostics, Pushing the Boundaries
  
• Feature Articles: Metabolomics Advances Reshape Dx Arena
  

• Insight & Intelligence™

• More »

• Moving Genomics Closer to the Clinic
  May 16, 2013
  Foundation Medicine and Memorial Sloan-Kettering Cancer Center are working to translate genomic information into personalized cancer treatment.
• Your Genes, Your Choice?
  May 9, 2013
  Critics say the American College of Medical Genetics and Genomics’ recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy.
• Detecting Acquired Drug Resistance in Cancer
  April 30, 2013
  New methods allow noninvasive analysis in blood plasma.
• 10 Predictions That Will Transform Healthcare
  January 22, 2013
  Peer into GEN's crystal ball for a glimpse of what's to come.
• 7 Biotech Trends for the Coming Year
  January 7, 2013
  What does 2013 hold for the industry?

• GEN News Highlights

• More »

• Lophius Wins $469K to Develop MS Diagnostic
  
• Techne Buys Bionostics for $104M
  
• Study: Genetic Testing Uptake within Cancer-Affected Families Remains Low
  
• Biomarker Study Suggests Potential Alternative to Colonoscopy
  
• GSK Hits Trifecta with Melanoma Drug, Dx Approvals
  

• GEN Podcasts

• More »

• MICROSIZING GENETICS TESTING
  - Interview with James Landers, Ph.D., Professor of Chemistry, Professor of Mechanical Engineering, and Associate Professor of Pathology, University of Virginia
• BREATH TEST FOR DISEASE DIAGNOSIS
  - Interview with Masood Yousef, Ph.D., senior research assistant in the Welsh Centre for Printing and Coating, Swansea University School of Engineering

• Video Channel

• More »

• James M. Wilson, M.D., Ph.D., on Biotech's Past & Future
  
• Stelios Papadopoulos, Ph.D., Comments on Biotech & Society
  

• BLOG Biotech

• More »

• Preliminary Thoughts on the Implications of Prometheus v. Mayo for Biotechnology
  
• Personalized Medicine Takes a Hit
  
• The Holes in Whole Genome Sequencing
  
• Drawing Out Cancer With Biomarkers
  
• The Nonprofit 'Diagnostics For All' Provides a Lesson For Us All
  

• New Products

• More »

Swift Biosciences BRAF Mutation Detection myT BRAF-Ultra, an ultrasensitive version of myT BRAF, provides 0.01% sensitivity down to single-copy detection of BRAF mutations. myT BRAF-Ultra can detect less than 10 copies of mutant BRAF V600E/K with low breakthrough amplification from a backg

• Webinars

• More »

• GEN Web Brief: Personal Exomes: 5 Insights for Interpretation and Diagnosis
  
• Supplier Webinars: Personalized Medicine Through Integrated Next Generation Sequencing Webinar
  

• Events

• More »

• Molecular Diagnostics for Infectious Disease
  2013 August 21 - August 22 Washington, DC, UNITED STATES
• Molecular Profiling of Circulating Tumor Cells
  2013 August 21 - August 22 Washington, DC, UNITED STATES

• Application Notes

• More »

• SepsiTest™: Culture-Independent Molecular Diagnosis of Bacterial and Fungal Infections of Joints and Bones
  
• Mastermix 16S – Ultra Sensitive Detection of Microbial DNA
  

• GEN Polls

• More »

• Genome Sequencing and Patient Autonomy